Recent treatment guidelines recommend treatment of PAH with macitentan (endothelin-1 receptor blocker), sildenafil (PDE5-inhibitor), iloprost (prostacyclin analog), or newly introduced riociguat (sGC stimulator) [43]. The gene discussed is SGCB; the disease is pulmonary arterial hypertension.